Investigating the safety and compliance of using csDMARDs in rheumatoid arthritis treatment through face-to-face interviews: a cross-sectional study in China
Jiaying Sun(Harbin Medical University), Zhiyi Zhang(First Affiliated Hospital of Harbin Medical University), Siming Dai(Harbin Medical University), Xin Yu(Rutgers, The State University of New Jersey), Ling Zhang(Wuhan University of Science and Technology), Yajing Feng(Zhengzhou University)
Cited by 13
Related Papers
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
|The Lancet Respiratory Medicine|2018|477
Cadmium-induced apoptosis of Leydig cells is mediated by excessive mitochondrial fission and inhibition of mitophagy
|Cell Death and Disease|2022|115
Influenza vaccination rate and its association with chronic diseases in China: Results of a national cross-sectional study
|Vaccine|2020|96
Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway
|International Immunopharmacology|2015|74
An Enquiry into the Professional Competence of Inclusive Education Teachers in Beijing: Attitudes, Knowledge, Skills, and Agency
|International Journal of Disability Development and Education|2015|47